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（1）采用一步电化学法，在金电极表面电聚合了网状 PPy 纳米线，在 优
电化学合成条件聚合电流密度为 0.477 mA/cm2，聚合时间为 1600 s 下合成了纳米
线均一且相互交织的多孔网状结构。网状 PPy 纳米线具有高比表面积和电导性，
经其修饰的电极电化学活性提高，阻抗下降，有利于药物控制释放。表面浸润性





层 PPy 膜（CVD-PPy 膜），以防止药物泄漏。实验探讨了氧化剂的浓度、剂量和
气相沉积温度对 CVD-PPy 膜形貌的的影响。实验结果表明氧化剂 FeCl3 无水乙醇
溶液浓度为 0.1 M 是 佳浓度，利用 10 μL、15 μL 和 20 μL 的氧化剂剂量可得到



































Inherently conducting polymers (ICPs), due to their electrical responses, are 
widely studied in drug delivery system. However, the improvement of ICPs in drug 
delivery system has met two big problems. One is the limitation of the drug loading 
level resulting from the limitation of doping and another is the limitation of the range 
of drugs due to their charges and sizes. Because of high specific surface area and 
conductivity, nanostructure ICPs have become attractive candidates to increase drug 
release efficiency. Polypyrrole (PPy) is the ICPs most widely explored for drug 
delivery purposes, due to its high conductivity, simple preparation, biocompatibility, 
non-toxicity and harmlessness.PPy nanowire with network structure is a typical 
material of ICPs. However, to the best of our knowledge, there is few report on the 
use of PPy nanowire network for controlled drug release. It’s no doubt that pores 
among PPy nanowires could become the drug containers. In this thesis, micro- and 
nano-pores formed in PPy nanowire network are used as drug storage containers for 
the first time. Therefore we successfully construct a novel controlled drug delivery 
system based on polypyrrole nanowire network and study its drug release effeciency. 
The main research contents and results are as following: 
(1) PPy nanowire network is prepared by one-step electrochemical deposition on 
Au electrode. Optimum synthesis conditions are determinated during preparing 
network structure by using the 0.477 mA/cm2 and 1600s as the polymerization current 
density and reaction time respectively. The PPy nanowires are uniform in diameter 
and twist and interwoven to form porours network structure. The high electroactive 
and low impedance of PPy nanowire network-coated Au electrode resulted from its 
high specific surface area and conductivity promotes the efficiency of controlled drug 
release. The surface wettability test suggests that PPy nanowire network has a 
superhydrophilic and lipophilic surface, providing the foundation for drug loading. 
(2) Adenosine 5’-triphosphate disodium salt (ATP) and dexamethasone (Dex) 















nanowires through porous network structure. 
(3) Another PPy film is synthesized on the surface of modified electrode by 
chemical vapour deposition (CVD) method in a dry vaccum environment to prevent 
drug from leaking out. Effects of reaction temperature, the concentration and dose of 
the oxidant on the morphology of CVD-PPy film are investigated. The results show 
that 0.1 M FeCl3 ethanol solution is the best concentration and 10 μL, 15 μL and 20 
μL of the oxidant, respectively, could form three different thicknesses of CVD-PPy 
films at a fixed temperature of 60 ℃. 
(4) Drug release is based on the electrical switching of the ICPs redox states, 
accompanied by the change in polymer volume. Therefore, cyclic voltammetry (CV) 
is selected as controlled drug release method. Study the effects of different scan rates 
and thicknesses of CVD-PPy on the drug delivery efficiency. The results show that the 
faster the scan rate, the thinner the thickness of CVD-PPy film, the higher the drug 
release efficiency. 
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吡咯（Py）是一种五元杂环分子，分子式为 C4H4NH。PPy 可以通过 Py 单
体的化学氧化或电化学氧化得到，其化学结构是吡咯环的 2, 5 偶联，是一种半结

















杂和 n 型掺杂。PPy 的本征态处于半导体或绝缘体态，p 型或 n 型掺杂后转变为
导电态。PPy 的 p 型掺杂是指其主链失去电子的同时伴随着对阴离子的嵌入，n
型掺杂时指其主链得到电子的同时伴随对阳离子的嵌入，阳离子的嵌入使 PPy
整体呈现电中性，如图 1-1 B、C 所示。 
依据 PPy 独特的掺杂（Doping）/脱掺杂（Dedoping）性能，当 PPy 在氧化
态与还原态之间变化时，会伴随着掺杂离子（Dopant）进入与离开 PPy，以维持





图 1-1 PPy 的分子结构（A）和两种掺杂形态（B：p 型掺杂，C：n 型掺杂），其
中 A-代表掺杂阴离子，X+代表阳离子。 
Fig. 1-1 The molecular structure of PPy (A) and two types doping of PPy (B: p-type 
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广泛的研究和应用。其中，PPy 已成为该领域应用 多的 ICPs 材料[33]。 







以 PPy 为例，当 PPy 在氧化和还原态转变时，为了维持骨架的电荷平衡，
此过程会伴随着掺杂离子的进入和脱离[27, 28]，利用这原理，药物可作为掺杂
离子而实现药物的储存和释放。当掺杂离子为小体积的阴离子药物时，当施加一
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药物释放。 








PPy 膜，并利用-1.0 V（vs SCE）的阴极脉冲将谷氨酸盐从 PPy 膜中释放出去，
首次报道了从 ICPs 材料中控制释放生物活性分子。Miller 等 初想用谷氨酸钠
作为掺杂剂直接聚合 PPy，但没有实现，于是将掺杂剂换成高氯酸钠（NaClO4），
得到了 PPy/ClO4 膜。接着将膜置于含谷氨酸钠的溶液中，通过施加 0 V 到-1.0 V 
（vs SCE）电位，将谷氨酸阴离子合并入 PPy 膜中。当施加-1.0 V 时，PPy 处于
还原状态，ClO4
-脱离 PPy 膜；当再施加 0 V 氧化电位时，谷氨酸阴离子就会进
入 PPy 膜中，接着利用-1.0 V 的阴极脉冲将谷氨酸盐从 PPy 膜中释放出去，其电
刺激下的释药量是非电刺激释放的 14 倍，可见电化学控制释放的高效性。控制
释放过程见图 1-2A，掺杂了可移动阴离子的 ICPs 膜在还原过程中释放阴离子药
物，同时伴随着 ICPs 膜的收缩，称之为阴离子驱动。Konturri 等[35]采用类似的
方法，在含 Na+离子和特定阴离子的溶液中施加 0.5 V 到-0.8 V 循环伏安电位，
将水杨酸（salicylate anion）、萘普生（naproxen anion）、烟酸钠（nicoside anion）
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图 1-2 ICPs 的两种不同离子导致的驱动机制[33]。（A）阴离子驱动，（B）阳离
子驱动。 
Fig. 1-2 Anion-driven actuation (A) and Cation-driven actuation (B) mechanism of 
ICPs. 
 









系控制释放 ATP 阴离子。在 PPy 制备过程中，阴离子药物以 p 型掺杂（图 1-1B）
的方式直接进入 PPy 骨架实现药物的固载。利用此法，作者成功合成了掺杂 ATP
的 PPy 内膜（PP-ATP）和掺杂氯离子的聚 N-甲基吡咯外膜及掺杂肝素的聚 N-
甲基吡咯两种外膜。通过电刺激调控内外膜氧化还原状态，调整 ATP 释放速率，
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